You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ERYPED Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Eryped, and when can generic versions of Eryped launch?

Eryped is a drug marketed by Azurity and is included in two NDAs.

The generic ingredient in ERYPED is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ERYPED?
  • What are the global sales for ERYPED?
  • What is Average Wholesale Price for ERYPED?
Drug patent expirations by year for ERYPED
Drug Prices for ERYPED

See drug prices for ERYPED

Drug Sales Revenue Trends for ERYPED

See drug sales revenues for ERYPED

Recent Clinical Trials for ERYPED

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assouline-Dayan, Yehudith
Yehudith Assouline-Dayan

See all ERYPED clinical trials

Pharmacology for ERYPED

US Patents and Regulatory Information for ERYPED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity ERYPED erythromycin ethylsuccinate GRANULE;ORAL 050207-003 Mar 30, 1987 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Azurity ERYPED erythromycin ethylsuccinate GRANULE;ORAL 050207-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Azurity ERYPED erythromycin ethylsuccinate TABLET, CHEWABLE;ORAL 050297-003 Jul 5, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.